These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 16509926

  • 1. Race and sex: predictors of the severity of hyperparathyroidism in peritoneal dialysis patients.
    Fan SL, Chan A, Raftery MJ, Yaqoob MM.
    Nephrology (Carlton); 2006 Feb; 11(1):15-20. PubMed ID: 16509926
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A, Brossard JH, Patenaude JV, Albert C, Nassif E, Cantor T, Rousseau L, D'Amour P.
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [Abstract] [Full Text] [Related]

  • 4. Leptin and biochemical markers of bone turnover in dialysis patients.
    Zoccali C, Panuccio V, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F.
    J Nephrol; 2004 Jun; 17(2):253-60. PubMed ID: 15293526
    [Abstract] [Full Text] [Related]

  • 5. Higher incidence of cholelithiasis in chronic renal failure patients with secondary hyperparathyroidism undergoing peritoneal dialysis.
    Barut I, Tarhan OR, Baykal B, Demir M, Celikbas B.
    Ren Fail; 2007 Jun; 29(4):453-7. PubMed ID: 17497468
    [Abstract] [Full Text] [Related]

  • 6. Hyperparathyroidism and dialysis vintage.
    Chertow GM, Plone M, Dillon MA, Burke SK, Slatopolsky E.
    Clin Nephrol; 2000 Oct; 54(4):295-300. PubMed ID: 11076105
    [Abstract] [Full Text] [Related]

  • 7. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Oct; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 8. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK, Cardenas M, Bhansali A, Mittal BR, Behera A, Chanukya GV, Nahar U, Rao DS.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [Abstract] [Full Text] [Related]

  • 9. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 10. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R.
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of pruritus in children on peritoneal dialysis.
    Senturk N, Ozkaya O, Aytekin S, Bek K, Açikgöz Y, Aydin F, Bek Y, Turanli AY.
    Nephron Clin Pract; 2008 Oct; 109(3):c168-72. PubMed ID: 18663330
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?
    Wei M, Esbaei K, Bargman JM, Oreopoulos DG.
    Int Urol Nephrol; 2006 Oct; 38(2):317-22. PubMed ID: 16868704
    [Abstract] [Full Text] [Related]

  • 16. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?
    Coen G, Manni M, Mantella D, Pierantozzi A, Balducci A, Condò S, DiGiulio S, Yancovic L, Lippi B, Manca S, Morosetti M, Pellegrino L, Simonetti G, Gallucci MT, Splendiani G.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Fisher L, Fisher A.
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
    Panuccio V, Cutrupi S, Pizzini P, Mallamaci F, Tripepi G, Zoccali C.
    Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T, Yamamoto H.
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.